文献速递青光眼

基于IRIS登记系统的青光眼引流装置修复或取出危险因素分析

Risk Factors for Glaucoma Drainage Device Revision or Removal Using the IRIS Registry.
PubMed 文献 · Am J Ophthalmol · 2022-04-02

该回顾性队列研究纳入2013年1月1日至2018年12月31日在IRIS登记系统中接受青光眼引流装置植入的患者,共44,330例,其中3,354例后续接受修复或取出手术。慢性闭角型青光眼(HR=1.32)和干眼病(HR=1.30)与修复或取出风险升高相关,未知种族和未知民族与风险降低相关。多种人口学和临床因素可能影响引流装置使用寿命。

要点

  • 慢性闭角型青光眼(HR=1.32;P<.001)和干眼病(HR=1.30;P=.007)与青光眼引流装置修复或取出风险升高相关。
  • 未知种族(HR=0.83;P=.004)和未知民族(HR=0.68;P<.001)与修复或取出风险降低相关。
  • 男性(β=-25.96;P=.044)、未知种族(β=-55.28;P=.013)和右眼侧别(β=-38.67;P=.026)与平均修复或取出时间缩短相关。

核心结论

  • IRIS登记系统的规模和范围允许检测危险因素与青光眼引流装置修复或取出手术之间的细微关联。
  • 上述人口学和临床因素可能均对青光眼引流装置使用寿命产生影响,并可为青光眼患者的治疗选择提供信息。

研究设计与样本

  • 回顾性队列研究,纳入IRIS登记系统(Intelligent Research in Sight)中2013年1月1日至2018年12月31日期间接受青光眼引流装置植入的患者。
  • 共收集44,330例 distinct 患者,其中3,354例后续接受青光眼引流装置修复或取出手术。
  • 采用Kaplan-Meier生存曲线、使用Firth惩罚似然的Cox比例风险模型和多变量线性回归模型进行分析,主要结局指标为风险比(HR)和β系数估计值。

主要发现

  • 以青光眼引流装置修复或取出定义为失败,与失败风险降低显著相关的因素包括未知种族(HR=0.83;P=.004)和未知民族(HR=0.68;P<.001)。
  • 与青光眼引流装置修复或取出手术风险升高相关的因素包括存在慢性闭角型青光眼(HR=1.32;P<.001)和干眼病(HR=1.30;P=.007)。
  • 与青光眼引流装置修复或取出平均时间(天)缩短相关的因素包括男性(β=-25.96;P=.044)、未知种族(β=-55.28;P=.013)和右眼侧别(β=-38.67;P=.026)。
  • 与青光眼引流装置修复或取出平均时间增加相关的因素包括有既往眼部手术史(β=104.83;P<.001)和当前吸烟(β=38.15;P=.024)。

关键数值与推荐

  • 失败定义为青光眼引流装置修复或取出手术。
  • 未知种族:HR=0.83(P=.004),与失败风险降低相关。
  • 未知民族:HR=0.68(P<.001),与失败风险降低相关。
  • 慢性闭角型青光眼:HR=1.32(P<.001),与修复或取出风险升高相关。
  • 干眼病:HR=1.30(P=.007),与修复或取出风险升高相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To elucidate risk factors for revision or removal of glaucoma drainage devices (GDD) in glaucoma patients in the United States. DESIGN: Retrospective cohort study. METHODS: IRIS Registry (Intelligent Research in Sight) patients who underwent GDD insertion between January 1, 2013 and December 31, 2018 were included. Various demographic and clinical factors were collected. Kaplan-Meier survival plots, Cox proportional-hazard models utilizing Firth's Penalized Likelihood, and multivariate linear regression models were used. The main outcome measures were hazard ratios (HR) and beta coefficient (β) estimates. RESULTS: A total of 44,330 distinct patients underwent at least 1 GDD implantation, and 3354 of these underwent subsequent GDD revision or removal surgery. With failure defined as GDD revision/removal, factors significantly associated with decreased failure included unknown race (HR = 0.83; P = .004) and unknown ethnicity (HR = 0.68; P < .001). Factors associated with increased risk of GDD revision/removal surgery included presence of chronic angle-closure glaucoma (HR = 1.32; P < .001) and dry eye disease (HR = 1.30; P = .007). Additionally, factors associated with a decreased average time (in days) to GDD revision/removal included male sex (β = -25.96; P = .044), unknown race (β = -55.28; P = .013), and right-eye laterality (β = -38.67; P = .026). Factors associated with an increased average time to GDD revision/removal included having a history of a past eye procedure (β = 104.83; P < .001) and being an active smoker (β = 38.15; P = .024). CONCLUSIONS: The size and scope of the IRIS Registry allows for detection of subtle associations between risk factors and GDD revision or removal surgery. The aforementioned demographic and clinical factors may all have an impact on GDD longevity and can inform the treatment options available for glaucoma patients.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Hall NE, Chang EK, Samuel S, et al. Risk Factors for Glaucoma Drainage Device Revision or Removal Using the IRIS Registry. Am J Ophthalmol. 2022. PMID: 35381206. doi:10.1016/j.ajo.2022.03.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。